Insider Transactions Reported by 18 Insiders of IDEAYA Biosciences, Inc.

Symbol
IDYA on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

IDEAYA Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yujiro S. Hata President and CEO, Director $13,482,366 30 Jan 2026
Michael P. Dillon SVP, Chief Scientific Officer $3,311,116 04 Oct 2021
Jeffrey Stein Director $1,909,511 +$1,647,890 +630% 02 Mar 2026
Andres Ruiz Briseno Title: SVP, Head of Finance and Investor Relations $447,447 30 Jan 2026
Jason Throne Chief Legal Officer $445,023 27 Jun 2024
Paul A. Stone Chief Financial Officer $390,960 29 Aug 2023
Douglas B. Snyder SVP, General Counsel $35,165 30 Jan 2026
Stuart Dorman Chief Commercial Officer 30 Jan 2026
Timothy M. Shannon Director 07 Jun 2023
Darrin Beaupre Chief Medical Officer 30 Jan 2026
Scott W. Morrison Director 24 Jun 2025
Michael Anthony White Chief Scientific Officer 30 Jan 2026
Susan L. Kelley Director 31 May 2024
Joshua Bleharski Chief Financial Officer 30 Jan 2026
Catherine J. Mackey Director 24 Jun 2025
Malcolm Garret Hampton Director 24 Jun 2025
Wendy L. Yarno Director 24 Jun 2025
Terry J. Rosen Director 24 Jun 2025

Recent Insider Transactions by Companies or Individuals for IDEAYA Biosciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Jeffrey Stein IDYA Common Stock Purchase 1168% $1,647,890 $32.96 50,000 54,281 02 Mar 2026 Direct
Joshua Bleharski IDYA Stock Option (right to buy) Award 170,000 170,000 30 Jan 2026 Direct
Michael Anthony White IDYA Stock Option (right to buy) Award 190,000 190,000 30 Jan 2026 Direct
Stuart Dorman IDYA Stock Option (right to buy) Award 155,000 155,000 30 Jan 2026 Direct
Douglas B. Snyder IDYA Stock Option (right to buy) Award 130,000 130,000 30 Jan 2026 Direct
Andres Ruiz Briseno IDYA Stock Option (right to buy) Award 80,000 80,000 30 Jan 2026 Direct
Yujiro S. Hata IDYA Stock Option (right to buy) Award 600,000 600,000 30 Jan 2026 Direct
Darrin Beaupre IDYA Stock Option (right to buy) Award 175,000 175,000 30 Jan 2026 Direct
Douglas B. Snyder IDYA Common Stock Award 100.2% 1,041 2,080 28 Nov 2025 Direct
Andres Ruiz Briseno IDYA Common Stock Award 4.97% 1,253 26,466 28 Nov 2025 Direct
Wendy L. Yarno IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Jeffrey Stein IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Malcolm Garret Hampton IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Scott W. Morrison IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Catherine J. Mackey IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Terry J. Rosen IDYA Stock Option (right to buy) Award 20,000 20,000 24 Jun 2025 Direct
Douglas B. Snyder IDYA Common Stock Award 1,039 1,039 30 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.